A cosmetic cleansing composition, which is solid at about 25° C., is disclosed. The cosmetic cleansing composition includes up to about 90% by weight, based on a total weight of the cosmetic cleansing composition, of alkali metal salts of fatty acids (soaps), from about 1 to about 40% by weight, based on a total weight of the cosmetic cleansing composition, of amino acid surfactant(s), and from about 0.05 to about 10% by weight, based on a total weight of the cosmetic cleansing composition, of citric acid ester and/or salt(s) of citric acid.

It is an object of the present disclosure to provide an agent for coloring keratinous material, in particular human hair, comprising (a1) at least one linear amino-functionalized silicone polymer, and (a2) at least one pigment, and (a3) at least one polysaccharide, exemplified in that the agent is free of silicone resins.

A second subject matter is a method for dyeing keratin material, wherein the agent is applied to the keratin material.

It is an object of the present disclosure to provide an agent for coloring keratinous material, in particular human hair, comprising (a1) at least one linear amino-functionalized silicone polymer, and (a2) at least one pigment, and (a3) at least one polysaccharide, exemplified in that the agent is free of silicone resins.

A second subject matter is a method for dyeing keratin material, wherein the agent is applied to the keratin material.

An anhydrous topical composition provides a water repellent surface. The anhydrous topical composition has at least one film former with surface tension lower than 35 dynes/cm, at least one particle having a hydrophobic surface or a hydrophobic surface treatment, and a volatile topical carrier.

Disclosed herein are cohesive soft tissue fillers, for example, dermal and subdermal fillers, based on hyaluronic acids and pharmaceutically acceptable salts thereof. In one aspect, hyaluronic acid-based compositions described herein include a therapeutically effective amount of at least one anesthetic agent, for example, lidocaine. The present hyaluronic acid-based compositions including lidocaine have an enhanced stability and cohesivity, relative to conventional compositions including lidocaine, for example when subjected to sterilization techniques or when stored for long periods of time. Methods and processes of preparing such hyaluronic acid-based compositions are also provided.

A graft copolymer comprising: a core polymer comprising a crosslinked or non-crosslinked polysaccharide, a plurality of primary graft polymers covalently grafted to the core polymer, a plurality of secondary graft polymers covalently grafted to each primary graft polymer, an injectable dermal aesthetic formulation comprising such a graft copolymer and a method of preparing such a graft copolymer.

The invention relates to an aerosol device comprising:—a container containing:—one or more propellants, and—a composition comprising one or more sebum-absorbing powders with a sebum up-take of greater than or equal to 35 ml/100 g, it being possible for the propellant(s) to be present in the composition or, in the container, separate from the composition,—a means for dispensing said composition comprising:—a body (3) that is open at its two opposite axial ends,—an engaging part (10) that is open at its two opposite axial ends, at least partially defining a dispensing orifice (12).

The present invention relates to a hydrogel composition having excellent gel stability while exerting excellent feeling of use. That is, the present invention relates to a hydrogel composition comprising components (A) to (D) below: (A) water in an amount of 50 mass % or more and 90 mass % or less; (B) an anionic water-soluble polymer compound comprising 80 mass % or more of carboxymethylcellulose or a salt thereof; (C) a crosslinking agent that forms ionic crosslinking with an anionic functional group; and (D) a nonionic water-soluble polymer compound, in an amount of 2.5 mass % or more and 8 mass % or less, represented by formula (1) below:

##STR00001##

The present invention provides an antioxidant, an ROS inhibitor, an antioxidant enzyme production promoter, an antioxidant cosmetic, a UV care cosmetic, a prophylactic or therapeutic agent for gastrointestinal tract inflammation, and an antioxidant food or beverage, each containing an enzymatically synthesized glycogen (ESG) or an α-amylase digest (RG) thereof, as well as use for enhancing an antioxidative effect in vivo.

The present invention provides an antioxidant, an ROS inhibitor, an antioxidant enzyme production promoter, an antioxidant cosmetic, a UV care cosmetic, a prophylactic or therapeutic agent for gastrointestinal tract inflammation, and an antioxidant food or beverage, each containing an enzymatically synthesized glycogen (ESG) or an α-amylase digest (RG) thereof, as well as use for enhancing an antioxidative effect in vivo.